KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Short-term Investments (2022)

Historic Short-term Investments for TherapeuticsMD (TXMD) over the last 1 years, with Q4 2022 value amounting to $11.2 million.

  • TherapeuticsMD's Short-term Investments changed N/A to $11.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was $11.2 million, marking a year-over-year change of. This contributed to the annual value of $11.2 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that TherapeuticsMD reported Short-term Investments of $11.2 million as of Q4 2022.
  • TherapeuticsMD's Short-term Investments' 5-year high stood at $11.2 million during Q2 2022, with a 5-year trough of $11.2 million in Q2 2022.